| Report ID | 283284 |
| Drug Identification Number | 02522403 |
| Brand name | VAXNEUVANCE |
| Common or Proper name | Pneumococcal 15-valent conjugate vaccine |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F |
| Strength(s) | 2MCG 2MCG 2MCG 2MCG 30MCG 4MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 10 DOSE |
| ATC code | J07AL |
| ATC description | BACTERIAL VACCINES |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2026-04-20 |
| Actual start date | 2026-04-20 |
| Estimated end date | 2026-04-24 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-04-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-04-20 | French | Compare |
| v3 | 2026-04-20 | English | Compare |
| v2 | 2026-04-20 | French | Compare |
| v1 | 2026-04-20 | English | Compare |
Showing 1 to 4 of 4